More than 15 million Americans are now losing weight with GLP-1 drugs. The medications — drugs like Ozempic, Wegovy and Mounjaro that were originally created to treat type 2 diabetes — have been shown to produce superior weight loss effects with little risk, according to a 2023 study. Read more…